名称 | 銘柄コード | 市場 | 種別 |
---|---|---|---|
InVivo Therapeutics Holdings Corporation | NVIV | NASDAQ | 普通株式 |
始値 | 安値 | 高値 | 終値 | 前日終値 |
---|---|---|---|---|
0.3207 |
最新ニュース
日付 | 時間 | ソース | タイトル |
---|---|---|---|
2024/3/22 | 03:23 | EDGAR2 | Form 25-NSE - Notification filed by national security.. |
2024/2/15 | 04:53 | EDGAR2 | Form SC 13G/A - Statement of acquisition of beneficial.. |
2024/2/14 | 10:09 | EDGAR2 | Form SC 13G/A - Statement of acquisition of beneficial.. |
2024/2/08 | 04:12 | EDGAR2 | Form 4/A - Statement of changes in beneficial ownership of.. |
2024/2/08 | 03:31 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
2024/2/07 | 02:08 | EDGAR2 | Form SC 13G/A - Statement of acquisition of beneficial.. |
2024/2/06 | 22:00 | EDGAR2 | Form 8-K - Current report |
2024/2/01 | 22:00 | EDGAR2 | Form 8-K - Current report |
2023/12/05 | 22:30 | EDGAR2 | Form DEF 14A - Other definitive proxy statements |
2023/12/02 | 06:30 | EDGAR2 | Form 8-K - Current report |
2023/12/01 | 00:31 | EDGAR2 | Form 8-K - Current report |
2023/11/09 | 06:31 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
2023/9/02 | 05:30 | EDGAR2 | Form 8-K - Current report |
2023/8/10 | 05:30 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |